These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31360750)

  • 1. Autoimmune bullous diseases during pregnancy: Solving common and uncommon issues.
    Patsatsi A; Marinovic B; Murrell D
    Int J Womens Dermatol; 2019 Jul; 5(3):166-170. PubMed ID: 31360750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Autoimmune Bullous Diseases During Pregnancy and Lactation: A Review Focusing on Pemphigus and Pemphigoid Gestationis.
    Genovese G; Derlino F; Berti E; Marzano AV
    Front Pharmacol; 2020; 11():583354. PubMed ID: 33117178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Autoimmune Bullous Disorders in Pregnancy.
    Kushner CJ; Concha JSS; Werth VP
    Am J Clin Dermatol; 2018 Jun; 19(3):391-403. PubMed ID: 29392620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of autoimmune diseases in preconception, pregnancy and lactation.
    Cozzani E; Cioni M; Gariazzo L; Burlando M; Parodi A
    G Ital Dermatol Venereol; 2019 Jun; 154(3):299-304. PubMed ID: 30375218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Practical management of the most common autoimmune bullous diseases].
    Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM
    Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.
    Makol A; Wright K; Amin S
    Drugs; 2011 Oct; 71(15):1973-87. PubMed ID: 21985166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune bullous diseases in pregnancy: an overview of pathogenesis, clinical presentations, diagnostics and available therapies.
    Vičić M; Marinović B
    Ital J Dermatol Venerol; 2023 Apr; 158(2):99-109. PubMed ID: 37153944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of autoimmune blistering diseases in pregnancy.
    McPherson T; Venning VV
    Dermatol Clin; 2011 Oct; 29(4):585-90. PubMed ID: 21925002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach.
    Fagundes PPS; Santi CG; Maruta CW; Miyamoto D; Aoki V
    An Bras Dermatol; 2021; 96(5):581-590. PubMed ID: 34304937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study.
    Tan AJ; Archila M; Barbieri JS; Mostaghimi A; Scherer AM; Perez-Chada LM; Asgari MM; Gelfand JM; Noe MH
    Arch Dermatol Res; 2024 Apr; 316(5):125. PubMed ID: 38637431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune bullous disorder flares following severe acute respiratory syndrome coronavirus 2 vaccination: a case series.
    Rasner CJ; Schultz B; Bohjanen K; Pearson DR
    J Med Case Rep; 2023 Sep; 17(1):408. PubMed ID: 37749657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Translated article] Biological and immunosuppressive medications in pregnancy, breastfeeding and fertility in immune mediated diseases.
    Ibarra Barrueta O; García Martín E; López Sánchez P; Ramírez Herráiz E; Merino Bohórquez V; Ais Larisgoitia A
    Farm Hosp; 2023; 47(1):T39-T49. PubMed ID: 36732114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, demographic and immunopathological spectrum of subepidermal autoimmune bullous diseases at a tertiary center: A 1-year audit.
    De D; Khullar G; Handa S; Saikia UN; Radotra BD; Saikia B; Minz RW
    Indian J Dermatol Venereol Leprol; 2016; 82(3):358. PubMed ID: 27088957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of autoimmune bullous diseases in France: a nationwide network of 30 centers.
    Meyer N; Paul C; Joly P
    Dermatol Clin; 2011 Oct; 29(4):659-62. PubMed ID: 21925014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interpretation of 2021 French Guidelines for the Therapeutic Management of Bullous Pemphigoid].
    Wang SH; Zuo YG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Oct; 44(5):828-836. PubMed ID: 36325781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
    Götestam Skorpen C; Hoeltzenbein M; Tincani A; Fischer-Betz R; Elefant E; Chambers C; da Silva J; Nelson-Piercy C; Cetin I; Costedoat-Chalumeau N; Dolhain R; Förger F; Khamashta M; Ruiz-Irastorza G; Zink A; Vencovsky J; Cutolo M; Caeyers N; Zumbühl C; Østensen M
    Ann Rheum Dis; 2016 May; 75(5):795-810. PubMed ID: 26888948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and immunosuppressive medications in pregnancy, breastfeeding and fertility in immune mediated diseases.
    Ibarra Barrueta O; García Martín E; López Sánchez P; Ramírez Herráiz E; Merino Bohórquez V; Ais Larisgoitia A
    Farm Hosp; 2023; 47(1):39-49. PubMed ID: 36710223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usage of Tacrolimus and Mycophenolic Acid During Conception, Pregnancy, and Lactation, and Its Implications for Therapeutic Drug Monitoring: A Systematic Critical Review.
    Le HL; Francke MI; Andrews LM; de Winter BCM; van Gelder T; Hesselink DA
    Ther Drug Monit; 2020 Aug; 42(4):518-531. PubMed ID: 32398419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.